TOPAMAX- topiramate tablet, coated United States - English - NLM (National Library of Medicine)

topamax- topiramate tablet, coated

remedyrepack inc. - topiramate (unii: 0h73wjj391) (topiramate - unii:0h73wjj391) - topamax ® is indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. topamax ® is indicated as adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with lennox-gastaut syndrome in patients 2 years of age and older. topamax ® is indicated for the preventive treatment of migraine in patients 12 years of age and older. none. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to topamax ® during pregnancy. patients should be encouraged to enroll in the north american antiepileptic drug (naaed) pregnancy registry if they become pregnant. this registry is collecting information about the safety of antiepileptic drugs during pregnancy. to enroll, patients can call the toll-free number 1-888-233-2334. information about th

REMOTIV 250 Israel - English - Ministry of Health

remotiv 250

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 250 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions. treatment is recommended for up to 24 weeks.

REMOTIV 500 Israel - English - Ministry of Health

remotiv 500

rafa laboratories ltd - hyperici herba extractum siccum - film coated tablets - hyperici herba extractum siccum 500 mg - other antidepressants - symptoms of mild to moderate depression including: dejected mood, mood lability, inner restlessness, anxiety, states of tension and the difficulty in falling asleep and sleeping through the night which is associated with these conditions.treatment is recommended for up to 24 weeks.

ENVIROMAX BIFENTHRIN 80SC RESIDUAL INSECTICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

enviromax bifenthrin 80sc residual insecticide

enviromax technologies pty ltd - bifenthrin - insecticide - apple | banana | bowling green | commercial area - general | commercial building/structure - external | commercial building/stru - african black beetle | ants (except red imported fire ant) | aphid | apple dimpling bug - c. liebknechti | argentine stem weevil | banana flower thrips | banana scab moth | bill bug | biting midge | black or black house ant | caterpillar | coastal brown ant | cockroach | codling moth | corn earworm | cutworm | flea | fly | funnel ant | geranium plume moth | greenhouse whitefly | lawn armyworm | light brown apple moth | longtailed mealy bug | looper | mealy bug | meat ant | mosquito | native budworm or bollworm | paper nest wasp | pear looper | plague thrips | poinsettia whitefly | sod webworm | spider | stinging ant | subterranean termite | sugar ant | termite | termite - excluding m. darwiniensis | tick - except paralysis tick | two spotted mite | adult mosquitoes | banded sugar ant | billbug | budworm | campylomma livida | cotton bollworm | cotton whitefly | ctenocephalides spp. | drywood termite | grass caterpillar | grass grub | ground fleas | heliothis | la plata weevil | lamprosema octasema | large coc

ENVIROMAX BIFENTHRIN 80SC PROFESSIONAL INSECTICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

enviromax bifenthrin 80sc professional insecticide

enviromax technologies pty ltd - bifenthrin - insecticide - apple | banana | bowling green | commercial building/structure - external | commercial building/structure-internal | commercial/ - african black beetle | ants (except red imported fire ant) | aphid | apple dimpling bug - c. liebknechti | argentine stem weevil | banana flower thrips | banana scab moth | bill bug | biting midge | black or black house ant | caterpillar | coastal brown ant | cockroach | codling moth | corn earworm | cutworm - agrotis spp. | flea | flower thrip | fly | funnel ant | geranium plume moth | greenhouse whitefly | helicoverpa spp. | lawn armyworm | light brown apple moth | longtailed mealy bug | looper | meat ant | mosquito | native budworm or bollworm | paper nest wasp | pear looper | plague thrips | poinsettia whitefly | sod webworm | spider | stinging ant | subterranean termite | subterranean termite ex. m. darwiniensis | subterranean termite incl. m.darwiniensi | sugar ant | thrips simplex | tick - except paralysis tick | timber beetle | two spotted mite | adult mosquitoes | banded sugar ant | billbug | budworm | campylomma livida | coptotermes spp. | corn earworm | cotton bollworm | cotton whitefly | ctenoceph

SIGMAXIN digoxin 250microgram tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sigmaxin digoxin 250microgram tablet blister pack

aspen pharma pty ltd - digoxin, quantity: 250 microgram - tablet, uncoated - excipient ingredients: magnesium stearate; rice starch; lactose monohydrate; oxidised maize starch; hydrolysed maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

SIGMAXIN PG digoxin 62.5microgram tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

sigmaxin pg digoxin 62.5microgram tablet bottle

aspen pharma pty ltd - digoxin, quantity: 0.0625 microgram - tablet, uncoated - excipient ingredients: lactose monohydrate; rice starch; magnesium stearate; hydrolysed maize starch; povidone; indigo carmine; oxidised maize starch - congestive heart failure - sigmaxin is useful regardless of whether the failure is predominantly of the left or right ventricle, or involves both sides of the heart. it is particularly useful in heart failure resulting from chronic overload (hypertension, valvular lesions, atherosclerotic heart disease) in which the supply of energy is not impaired. sigmaxin does not cause major benefit in situations in which the metabolic energy supply is compromised as in thyrotoxicosis, hypoxia, and severe thiamine deficiency. atrial fibrillation - because sigmaxin depresses conduction in the atrioventricular bundle, producing a slower ventricular beat, it is valuable in atrial fibrillation. it will frequently convert atrial flutter into fibrillation and, upon withdrawal of the drug, normal sinus rhythm may be restored. paroxysmal atrial tachycardia - sigmaxin may relieve or prevent an attack, but its use in paroxysmal ventricular tachycardia is dangerous.

Maxunitech Prohexon New Zealand - English - Ministry for Primary Industries

maxunitech prohexon

max(rudong) chemicals co., ltd. - prohexadione-calcium - prohexadione-calcium 100 g/kg - plant growth regulator

INOmax European Union - English - EMA (European Medicines Agency)

inomax

linde healthcare ab - nitric oxide - hypertension, pulmonary; respiratory insufficiency - other respiratory system products - inomax, in conjunction with ventilatory support and other appropriate active substances, is indicated:for the treatment of newborn infants ≥34 weeks gestation with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation;as part of the treatment of peri- and post-operative pulmonary hypertension in adults and newborn infants, infants and toddlers, children and adolescents, ages 0-17 years in conjunction to heart surgery, in order to selectively decrease pulmonary arterial pressure and improve right ventricular function and oxygenation.

ANGIOMAX- bivalirudin injection, powder, lyophilized, for solution United States - English - NLM (National Library of Medicine)

angiomax- bivalirudin injection, powder, lyophilized, for solution

the medicines company - bivalirudin (unii: tn9bex005g) (bivalirudin - unii:tn9bex005g) - bivalirudin 250 mg - angiomax is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (pci) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. angiomax is contraindicated in patients with: risk summary there are no data available on use of angiomax in pregnant women to inform a drug-associated risk of adverse developmental outcomes. reproduction studies in rats and rabbits administered subcutaneously doses up to 1.6 times and 3.2 times the maximum recommended human dose (mrhd) of 15 mg/kg/day based on body surface area (bsa) during organogenesis, respectively, revealed no evidence of fetal harm. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recogniz